Skip to main content
. 2021 Jul 30;36(1):1702–1714. doi: 10.1080/14756366.2021.1945049

Figure 9.

Figure 9.

CAI–CORM hybrids of types 19–22 incorporating sulphonamide, 7-hydroxycoumarin, 7-aminocoumarin and 6-hydroxysulphocoumarin as scaffolds with CA inhibitory properties and hexacarbonyl dicobalt(II) as CO releasing fragment.